Neosense Technologies AB is an innovative start-up company based in Stockholm, Sweden. As a medical company, Neosense specializes in supplying intensive care units for critically ill patients with continuous oxygen monitoring systems. Our mission is to save lives and reduce permanent injuries for preterm babies in neonatal care.

Extremely preterm babies require advanced intensive care due to underdeveloped organs and a weak immune system. To provide them with optimal care, Neosense offers solutions for monitoring and controlling blood oxygenation in real-time. This is crucial as the precise control of oxygen supply is essential for minimizing the risk of acute and permanent complications.

Our world-unique sensor allows healthcare providers worldwide to measure, monitor, and control blood oxygenation for critically ill patients with outstanding capability. With Neosense Technologies, healthcare providers can ensure improved control and safety for critically ill patients, leading to a reduction in incidence of permanent damages and mortality. Trust in Neosense to provide cutting-edge technology for better patient care